Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lippis Daniel J.
CVP, TAVR at Edwards Lifesciences. Filing since 7 Mar 2024.
CIK 0002004380
Company
Date
Role
Action
Shares
Amount
Of holding
EW
Edwards Lifesciences
8 Oct 2026
CVP, TAVR
Sold on a plan
619
$53.02K
1.5%
EW
Edwards Lifesciences
11 Sep 2026
CVP, TAVR
Sold on a plan
619
$54.17K
1.5%
EW
Edwards Lifesciences
11 Aug 2026
CVP, TAVR
Sold on a plan
619
$56.97K
1.5%
EW
Edwards Lifesciences
10 Jul 2026
CVP, TAVR
Sold on a plan
619
$56.76K
1.5%
EW
Edwards Lifesciences
30 Jun 2026
CVP, TAVR
Sold on a plan
619
$56.58K
1.5%
EW
Edwards Lifesciences
18 May 2026
CVP, TAVR
Sold on a plan
620
$50.31K
1.5%
EW
Edwards Lifesciences
4 May 2026
CVP, TAVR
Sold on a plan
1,019
$85.58K
2.9%
EW
Edwards Lifesciences
1 May 2026
CVP, TAVR
Sold on a plan
1,019
$84.58K
2.9%
EW
Edwards Lifesciences
6 Apr 2026
CVP, TAVR
Sold on a plan
1,019
$82.52K
2.9%
EW
Edwards Lifesciences
11 Mar 2026
CVP, TAVR
Sold on a plan
1,019
$87.00K
2.9%
EW
Edwards Lifesciences
9 Jan 2026
CVP, TAVR
Sold on a plan
1,019
$87.33K
4.4%
EW
Edwards Lifesciences
12 Dec 2025
CVP, JAPAC
Sold on a plan
1,019
$85.63K
4.4%
EW
Edwards Lifesciences
10 Nov 2025
CVP, JAPAC
Sold on a plan
1,020
$84.20K
4.4%
EW
Edwards Lifesciences
28 Jul 2025
CVP, JAPAC
Sold at will
4,114
$326.90K
15.8%
EW
Edwards Lifesciences
9 May 2025
CVP, JAPAC
Sold on a plan
330
$24.56K
1.2%
EW
Edwards Lifesciences
8 Apr 2025
CVP, JAPAC
Sold on a plan
300
$21.18K
1.3%
EW
Edwards Lifesciences
10 Mar 2025
CVP, JAPAC
Sold on a plan
400
$27.79K
1.7%
EW
Edwards Lifesciences
13 Feb 2025
CVP, JAPAC
Sold on a plan
500
$38.17K
2.1%
EW
Edwards Lifesciences
16 Jan 2025
CVP, JAPAC
Sold on a plan
500
$34.38K
2.1%
EW
Edwards Lifesciences
16 Dec 2024
CVP, JAPAC
Sold on a plan
2,500
$185.20K
9.7%
EW
Edwards Lifesciences
11 Jul 2024
CVP, JAPAC
Sold on a plan
500
$47.09K
2.1%
EW
Edwards Lifesciences
20 Jun 2024
CVP, JAPAC
Sold on a plan
535
$48.15K
2.2%
EW
Edwards Lifesciences
7 May 2024
CVP, JAPAC
Sold on a plan
857
$73.36K
3.5%
EW
Edwards Lifesciences
9 Apr 2024
CVP, JAPAC
Sold on a plan
857
$79.14K
4.7%
EW
Edwards Lifesciences
7 Mar 2024
CVP, JAPAC
Sold on a plan
1,715
$156.03K
9.1%
25 decisions on file.
